Resmed Inc. buy Mizuho
Start price
13.04.23
/
50%
€203.30
Target price
13.04.24
-
Performance (%)
-13.63%
End price
14.04.24
€175.60
Summary
This prediction ended on 14.04.24 with a price of €175.60. The price of Resmed Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.63%. Mizuho has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.73 are taken into consideration when calculating the performance. Mizuho has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 2.061% | 2.061% | -11.995% |
| iShares Core DAX® | -1.432% | 0.000% | 12.331% |
| iShares Nasdaq 100 | -0.386% | -0.595% | 4.688% |
| iShares Nikkei 225® | 1.448% | 5.269% | 18.051% |
| iShares S&P 500 | 0.114% | -0.217% | 1.388% |
Comments by Mizuho for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) is now covered by analysts at Mizuho. They set a "buy" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von Mizuho gewählte maximale Laufzeit wurde überschritten

